γ-Secretase inhibition affects viability, apoptosis, and the stem cell phenotype of endometriotic cells
Laura Ramirez Williams1, Kathrin Brüggemann1, Marina Hubert1
1Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, Münster, Germany.
Introduction:
Stem cells mediate cyclic regeneration of the endometrium. The upregulated expression of receptors and modulators of the notch signaling pathway in endometriosis suggests an involvement in the pathogenetic process. Here, we investigated the effects of notch pathway inhibition by a γ-secretase inhibitor (GSI) on stemness-associated properties of the epithelial endometriotic cell line 12Z and of primary endometriotic stroma cells.
Material And Methods:
12Z cells and primary endometriotic stroma cells of 7 patients were treated with or without GSI, and analyzed for changes in gene expression by TaqMan low-density arrays, quantitative PCR, and flow cytometry. The functional impact of GSI treatment was studied by MTT assay, cell cycle analysis, colony formation assay, annexin V apoptosis assay, and aldehyde dehydrogenase activity assays.
Results:
In 12Z cells, GSI treatment reduced aldehyde dehydrogenase activity and colony formation, and induced a shift to the G2/M phase of the cell cycle. Cell viability was decreased and apoptosis was increased in both cell models. GSI further induced transcriptional downregulation of the stemness-associated factors leukemia inhibitory factor receptor (LIFR), sex-determining region Y (SRY)- box 2, interferon-induced transmembrane protein 1, and hes-related family bHLH transcription factor with YRPW motif 1, in 12Z cells and in primary cell cultures. Downregulation of LIFR expression by GSI was confirmed at the protein level by flow cytometry.
Conclusions:
Our in vitro data suggest that application of GSI may be a worthwhile approach in the treatment of endometriosis that warrants further investigation.
Insights
Inhibition of the notch signaling pathway using a gamma-secretase inhibitor (GSI) reduced stemness properties in endometriosis cells. This suggests GSI may be a potential therapeutic strategy for endometriosis treatment.
Area of Science:
- Endocrinology and Reproductive Biology
- Cell Biology
- Molecular Biology
Background:
- Endometriosis is characterized by aberrant endometrial tissue growth outside the uterus.
- The notch signaling pathway is implicated in endometriosis pathogenesis due to upregulated receptor expression.
- Stem cells play a role in the cyclic regeneration of the endometrium, a process potentially affected in endometriosis.
Purpose of the Study:
- To investigate the effects of notch pathway inhibition on stemness properties of endometriotic cells.
- To evaluate the therapeutic potential of gamma-secretase inhibitors (GSIs) in endometriosis models.
Main Methods:
- Treatment of epithelial endometriotic cell line (12Z) and primary endometriotic stroma cells with a GSI.
- Analysis of gene expression using TaqMan low-density arrays and quantitative PCR.
- Assessment of functional changes via MTT assay, cell cycle analysis, colony formation, apoptosis assays, and aldehyde dehydrogenase activity assays.
- Confirmation of protein level changes (LIFR) using flow cytometry.
Main Results:
- GSI treatment decreased aldehyde dehydrogenase activity and colony formation in 12Z cells.
- GSI induced G2/M phase arrest, decreased cell viability, and increased apoptosis in both cell models.
- Transcriptional downregulation of stemness factors (LIFR, SOX2, IFI1, HERP1) was observed.
- Downregulation of Leukemia Inhibitory Factor Receptor (LIFR) protein was confirmed by flow cytometry.
Conclusions:
- Gamma-secretase inhibitor (GSI) treatment negatively impacts stemness-associated properties in endometriotic cells.
- In vitro findings suggest GSI as a potential therapeutic avenue for endometriosis.
- Further investigation is warranted to explore GSI's efficacy in endometriosis treatment.
Related Concept Videos
Adult Stem Cells
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Induced Pluripotent Stem Cells
Apoptosis
Feedback Inhibition


